胸腺瘤合并重症肌无力的外科治疗

来源 :中国基层医药 | 被引量 : 0次 | 上传用户:iowreoksbcx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察胸腺瘤合并重症肌无力(MG)的外科治疗效果。方法外科治疗21例胸腺瘤合并重症肌无力患者,按Osserman标准分为Ⅰ型1例、Ⅱa型7例、Ⅱb型10例、Ⅲ型3例。结果术后5例发生危象,均采用气管切开及辅助呼吸。随访半年至6年,平均36个月,5年内死亡4例。结论胸腺瘤合并重症肌无力者较常见,宜采用手术、放疗、化疗等综合治疗。围手术期应合理应用抗胆碱酯酶药,积极防治并发症及危象。 Objective To observe the surgical treatment of thymoma combined with myasthenia gravis (MG). Methods Surgical treatment of 21 patients with thymoma and myasthenia gravis according to Osserman criteria was divided into type Ⅰ in 1 case, type Ⅱ a in 7 cases, type Ⅱ b in 10 cases and type Ⅲ in 3 cases. Results 5 cases of postoperative crisis occurred, tracheotomy and assisted breathing. Follow-up six months to six years, an average of 36 months, 4 deaths within 5 years. Conclusion Thymoma with myasthenia gravis more common, should be used surgery, radiotherapy, chemotherapy and other comprehensive treatment. Perioperative period should be reasonable use of anticholinesterase drugs, active prevention and treatment of complications and crisis.
其他文献